November 2019 Funding Opportunities and Announcements
Please contact the Office of Corporate and Foundation Relations at cfr@gwu.edu for questions about any of these opportunities. Additional cancer-related funding opportunities and resources are available through Research Matters.

Questions about this "funding flash"? Contact us at cancercenter@gwu.edu. View previous issues here. Interested in subscribing to future updates? Click the button below:
Pancreatic Cancer Action Network 2020 Translational Research Grant
The Pancreatic Cancer Action Network has partnered with the Celgene Corporation to accelerate the development of novel therapies by establishing strong relationships between academia and industry through research grants. Funded projects will benefit from industry input and insight, leading to an accelerated translation into a therapeutic product.
Deadline: December 6, 2019
Amount and Project Period: $500,000 over 2 years, with potential to expand to a third year with additional funds
Eligibility : Applicants must have a doctoral degree (including PhD, MD, DO, DC, NC, DDS, DVM, ScD, DNS, PharmD or equivalent) in the biomedical sciences or in a field applicable to health science research and not currently be a candidate for a further doctoral degree. One co-PI may be named. The co-PI should be affiliated with any academic, medical or research institution, including international institutions. The co-PI must have a doctoral degree. Researchers can be a contact PI on one application and may be identified as a co-PI on a second application.
Reviewers: The 2020 Translational Research Grants will be awarded using a competitive, rigorous peer-review process. Applications will be evaluated by a scientific review committee composed of scientists from academia and industry who are respected for their accomplishments in pancreatic cancer, translational research and clinical trials. A pancreatic cancer research advocate will also serve on the committee to represent the collective patient perspective. The Celgene Corporation will not be involved in the review and selection process and will not have access to applications until they are funded.
American Lung Association Innovation Award
Since 1915, the American Lung Association Research Team has made significant contributions to the fight against lung disease by revolutionizing treatment and unlocking secrets of the body's immune system. They have funded breakthroughs in the fight against tuberculosis, identified genes that cause the development of lung cancer and cystic fibrosis, and developed innovative ways to treat respiratory distress syndrome. The award is intended to support highly promising investigators with stellar track records of accomplishment, who have the potential to advance the field of lung disease science.
Deadline: December 12, 2019
Amount and Project Period: $150,000 over 2 years
Eligibility : Successful applicants are investigators with evidence of prior excellence and productivity in the early stages of their careers; applicants must have held a K or R type award within three years prior to applying for this Lung Association award. The applicant must hold a doctoral degree and have a faculty appointment or equivalent with demonstrated institutional commitment (salary support, research space as evidenced by a Department Chair or equivalent letter) in a recognized academic or other not-for-profit research institution. The applicant’s publication record should reflect significant scientific contributions. Individuals who have been PI on two or more large federal research grants (even those with multiple PIs) in their career are not eligible to apply (examples of large federal grants are R01, U01, P01, and VA Merit). Note that being identified as a Co-Investigator does not count toward this restriction. 
Reviewers:  Applications determined by administrative review to be eligible for funding will go through a rigorous external peer review process.
American Lung Association Catalyst Award
The American Lung Association Catalyst Award is a mentored award meant to support outstanding investigators on the path to independence for research into the mechanisms of lung disease and general lung biology. Preference is given to projects that are novel; innovative in design/approach; utilize modern technologies; and incorporate a multidisciplinary collaborative training plan. 
Deadline: December 12, 2019
Amount and Project Period: $100,000 over 2 years
Eligibility : Applicants should be on-track to pursue a career in lung disease research with a mentor who has a demonstrated history of research experience and mentorship. The applicant must hold a doctoral degree and have a faculty appointment or equivalent with demonstrated institutional commitment. This award is intended to support investigators prior to receipt of career-development awards, like K08, K23, K99 or similar career-development award. Fellows and PhD post-docs are eligible to apply only if their Department Chair can assure a promotion to faculty status by the start of the award. MD applicants must have completed two years of post-doctoral research training by the start of the award. Medical residents, those presently enrolled in a degree program (e.g., graduate students), and established investigators are not eligible to apply.
Reviewers:  Applications determined by administrative review to be eligible for funding will go through a rigorous external peer review process.
Genentech Independent Medical Education
Grant requests must identify unmet educational needs of a target audience and demonstrate how the program will address the unmet educational needs, and encourage the improvement of medicine and healthcare. The selection of medium and format should be commensurate with the educational needs, the audience, learning preferences, geography, content, and other factors that contribute to educational effectiveness.
Deadline: Rolling
Amount and Project Period: Varies, commensurate based on project needs
Eligibility : Requests for funding an ACCME accredited program must be submitted by the organization accrediting the activity (the accredited provider) regardless of the dollar amount requested. Requests for funding other accredited programs (i.e., pharmacy, nursing, AAFP) must be submitted by the organization that is responsible for development of the program's content.
Reviewers: Genentech has a rolling review policy when evaluating funding requests for independent medical education, which means that they do not have a specific deadline for which funding requests must be received. This allows qualified requestors the opportunity to apply anytime during year. They do, however, recommend that you submit your request as early as possible. To ensure adequate opportunity for review, decisions are made on a case-by-case basis. You will usually hear back from Genentech prior to the project/program start date.